# Next Generation INCEPTA Implantable Cardioverter Defibrillator (ICD) and Cardiac Resynchronization Therapy (CRT-D) Field Following Study

> **NCT01227785** · — · COMPLETED · sponsor: **Guidant Corporation** · enrollment: 120 (actual)

## Conditions studied

- Sudden Cardiac Death
- Heart Failure

## Interventions

- **DEVICE:** INCEPTA ICD or CRT-D

## Key facts

- **NCT ID:** NCT01227785
- **Lead sponsor:** Guidant Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2010-10
- **Primary completion:** 2011-12
- **Final completion:** 2011-12
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2014-04-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01227785

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01227785, "Next Generation INCEPTA Implantable Cardioverter Defibrillator (ICD) and Cardiac Resynchronization Therapy (CRT-D) Field Following Study". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT01227785. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*